Please login to the form below

Not currently logged in
Email:
Password:

GS-5806

This page shows the latest GS-5806 news and features for those working in and with pharma, biotech and healthcare.

Gilead's RSV drug clears mid-stage trial

Gilead's RSV drug clears mid-stage trial

Late-stage data demonstrates GS-5806 is effective in treating the infection. Gilead Sciences has moved a stage closer to bringing the first antiviral drug for respiratory syncytial virus (RSV) infection ... The company presented the results of a study of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...

Infographics